scout
|Videos|December 13, 2022

COSMIC-313 and Advice to Community Oncologists Treating Advanced RCC

Dr Eric Jonasch reviews key efficacy outcomes from the COSMIC 313 trial, its clinical implications, and shares advice for community oncologists treating patients with advanced renal cell carcinoma.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME